Journal of Fungi最新文献

Powdery mildew poses a persistent threat to global vegetable and fruit production, particularly affecting leafy crops such as lettuce, spinach, and cucurbits. Conventional control strategies including chemical fungicides, biological agents, and resistant cultivars face limitations due to resistance development, environmental toxicity, and inconsistent field efficacy. This review explores the emerging role of nanotechnology, specifically nanoparticles (NPs) and nanosuspensions (NSs), in managing powdery mildew. Metallic nanoparticles and non-metallic variants demonstrate potent antifungal activity through mechanisms such as membrane disruption, reactive oxygen species (ROS) generation, and gene regulation. Encapsulated nano-fungicides and sprayable essential oils represent potential application methods that could enhance delivery precision and activate plant defense mechanisms against powdery mildew. Integrating the application of nanoparticles and nanosuspensions with smart and digital delivery systems could be a promising strategy for managing powdery mildew infestation in fruits and vegetables. Despite their potential, challenges including ecotoxicity, formulation stability, scalability, and regulatory gaps must be addressed. This review underscores the need for interdisciplinary research to advance safe, effective, and sustainable nano-enabled solutions for powdery mildew control.

Plant peptides represent a novel molecular tool in crop science due to their essential regulatory roles in plant growth, development, and responses to biotic and abiotic stresses. Although numerous bioactive plant peptides have been identified, a major gap remains in translating these discoveries into practical strategies for crop protection. Synthetic peptides are increasingly recognized as promising biological agents for enhancing crop productivity and protection in an environmentally sustainable manner. In this study, we demonstrate that the potato elicitor peptide StPep1, applied as a foliar spray at nanomolar concentrations (10-100 nM), strongly enhances resistance to the oomycete pathogen Phytophthora infestans in Solanum tuberosum cv. Gala under controlled climate chamber conditions. Preventive treatment 24 h prior to inoculation markedly reduced disease symptoms, with treated plants exhibiting a phenotype comparable to uninoculated controls. These findings highlight the potential of low-dose StPep1 as an environmentally friendly and cost-effective bioprotective agent, providing a foundation for future translational research and small-scale agricultural applications.

This study reports the first molecularly confirmed occurrence of Phlegmacium herculeum in Algeria, identified through morphological features and ITS sequence analysis (GenBank accession: PQ133121). Phytochemical profiling revealed a diverse composition of metabolites. SPME-GC-MS analysis detected volatile aldehydes (butanal, pentanal), organic acids (butanoic, pentanoic), terpenoids (limonene, 1,8-cineole), phenolics, and long-chain alkanes. Furthermore, the macrofungus has been extracted with organic solvents, and the obtained extracts have been analyzed via NMR and GC-MS, revealing the presence of organic acids (lactic, succinic, azelaic), fatty acids (palmitic, linoleic), and phenolic acids (protocatechuic, 4-hydroxybenzoic). DPPH-based analysis indicated that the antioxidant response of the crude extracts strengthened as the dose increased, with the ethyl acetate (EtOAc) extract exhibiting the highest inhibition and lowest IC₅₀, attributed to its rich phenolic content. The chloroform (CHCl₃) extract showed moderate activity, consistent with its composition of less polar metabolites such as fatty acids and terpenoids. Antibacterial assays revealed extract-specific effects: CHCl₃ strongly inhibited Staphylococcus aureus (18 mm), while EtOAc was more effective against Gram-negative strains, including Escherichia coli (18 mm) and Pseudomonas aeruginosa (13 mm). Cytotoxicity testing using Saccharomyces cerevisiae confirmed that both extracts were non-toxic, maintaining ≥90% cell viability. These findings highlight P. herculeum as a novel source of bioactive metabolites with antioxidant and antibacterial potential.

Ophiocordyceps sinensis, a fungus revered in traditional Asian medicine, is critically endangered due to climate change and overharvesting. Artificial cultivation is thus essential to meet demand and promote conservation. This review systematically analyses the decline of wild O. sinensis and evaluates the two primary cultivation strategies: in vitro mycelial fermentation and in vivo inoculation. We find that in vitro fermentation, while scalable and standardized, yields a chemical profile distinct from that of wild fungi. In vivo inoculation can produce fruiting bodies morphologically and chemically closer to wild specimens but is hampered by technical challenges in host rearing and low infection rates. By dissecting these bottlenecks, this review provides a framework for the sustainable cultivation of O. sinensis, crucial for preserving both a cornerstone of traditional medicine and the ecological balance of its native habitats.

Background: Nosocomial infections represent a significant clinical burden due to high morbidity, mortality and healthcare costs. Invasive fungal infections, particularly those caused by Candida species, are of growing concern due to increasing antifungal resistance, which limits therapeutic options and worsens patient outcomes. This study aimed to characterize the prevalence, species distribution, antifungal susceptibility profiles, and molecular mechanisms of resistance in clinical Candida isolates from hospitalized patients. Methods: A cross-sectional study was conducted involving 55 hospitalized patients, yielding 60 isolates from blood, secretions, fluids, and catheter tips. Species identification was performed using chromogenic media and confirmed by MALDI-TOF MS. Antifungal susceptibility testing followed CLSI M27-A4 broth microdilution guidelines for amphotericin B, fluconazole and 5-flucytosine. Gene expression of ERG2, ERG11 and MDR1 was evaluated by RT-qPCR after exposure to subinhibitory antifungal concentrations using the 2^-∆∆Ct method. Results:Candida albicans was the most frequent species, followed by Nakaseomyces glabratus, C. tropicalis and C. parapsilosis. Resistance varied among species, with elevated rates for fluconazole. ERG2 was notably overexpressed in amphotericin B-resistant isolates, while ERG11 and MDR1 showed species-dependent variation. Conclusions: Resistance mechanisms in Candida are species-specific and drug-dependent. Accurate species identification and understanding their molecular profiles are essential to guide targeted antifungal therapy and improve clinical outcomes.

The genus Gibellula (Cordycipitaceae, Hypocreales) comprises highly specialized, obligate pathogens that exclusively parasitize spiders. In this study, five new species were delimited based on morphological and phylogenetic evidence from a six-locus dataset (nrSSU, ITS, nrLSU, tef-1α, rpb1, rpb2). Specimens were collected from northeastern (Jilin and Liaoning Provinces) and southwestern (Yunnan Province) China. Phylogenetic analyses resolved these collections into five distinct, well-supported lineages, described as G. baishanensis, G. jilinensis, G. kunmingensis, G. paralongispora, and G. yunnanensis spp. nov. Among these, G. baishanensis and G. jilinensis were identified as sister taxa, whereas G. kunmingensis formed an independent lineage. Gibellula paralongispora was recovered as a sister to G. longispora, and G. yunnanensis as a sister to G. attenboroughii; both new species are supported by significant morphological distinctions (e.g., conidiophore length and conidial shape). This study provides detailed descriptions, illustrations, and morphological comparisons for these taxa, thereby enriching the taxonomy of Gibellula. Furthermore, the records from Jilin and Liaoning represent only the second documented occurrence of the genus in northeastern China, significantly expanding its known geographic range.

The white-rot fungus Coriolopsis trogii MUT3379 produces Lac3379-1 laccase at high yields due to the previous development of a robust fermentation process. Throughout the extended use of this strain, we observed the occurrence of substrate-specific guaiacol and ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)) oxidizing enzymes other than Lac3379-1 Since we did not succeed in producing these enzymes in significant amounts by conventional strain selection and fermentation tools, we developed an approach based on protoplast preparation and regeneration to isolate stable producers of these alternative oxidative enzymes from the complex multinucleate mycelium of C. trogii MUT3379. A cost-effective and efficient protocol for protoplast preparation was developed by using the enzymatic cocktail VinoTaste Pro by Novozymes. A total of 100 protoplast-derived clones were selected and screened to produce laccases and other oxidative enzymes. A variable spectrum of oxidative activity levels, including both high and low producers, was revealed. Notably, a subset of clones exhibited diverse guaiacol/ABTS positive enzymatic patterns. These findings suggest that it is possible to isolate different lineages from the mycelium of C. trogii MUT337, each producing a distinct pattern of oxidative enzymes. This highlights the potential of protoplast-mediated genome separation to uncover novel metabolic traits that would otherwise remain cryptic. These data hold outstanding significance for accessing and producing novel oxidative enzymes from native fungal populations.

The fungal pathogen Candida albicans can infect diverse tissues, a reflection of its broad metabolic repertoire. The transcription factor Adr1 is required for utilization of several citric acid cycle intermediates that are found in tissue. Many Adr1-activated genes encode enzymes with well-defined roles in citrate metabolism or gluconeogenesis. Here, we focus on HGT17 (C4_01070W, orf19.4682), an Adr1-activated gene that encodes a possible citrate transporter. We provide two lines of evidence that HGT17 is a key functional target of Adr1. First, forced expression of HGT17 in an adr1Δ/Δ mutant improves growth on citrate as a carbon source. Second, hgt17Δ/Δ and adr1Δ/Δ mutants incubated in citrate medium present similar gene expression defects compared to the wild type. Noteworthy is down-regulation in both mutants of citric acid cycle genes, glycolysis/gluconeogenesis genes, and ergosterol synthesis genes. These common features may reflect a specific effect of citrate as an inducer of citric acid cycle enzymes or a global effect of carbon and energy limitation. In either case, the results argue that reduced HGT17 expression contributes substantially to the impact of an adr1Δ/Δ mutation on growth and gene expression.

Fusarium wilt of melon, caused by Fusarium fungi, results in sizeable economic losses worldwide. In Russia, data on the species composition of the causative pathogens of this disease on melon are lacking. From 2022 to 2025, 19 Fusarium isolates from the Volgograd and Rostov regions were included in a study that included species identification using molecular phylogenetic analysis of the tef1 and rpb2 loci, morphological description, and pathogenicity assessment against the host plant and other members of the Cucurbitaceae family. Four Fusarium species were found to be involved in the pathogenesis of Fusarium wilt of melon in Russia: F. clavus (37% of the total number of isolates), F. annulatum (21%), F. cf. inflexum (21%), and F. brachygibbosum (21%). All identified species were isolated in the Volgograd Region, while only F. cf. inflexum and F. brachygibbosum were isolated in the Rostov Region. This study reports for the first time the high pathogenicity of F. cf. inflexum and F. brachygibbosum species associated with melon wilt. Morphological variability and different aggressiveness of isolates of the species F. brachygibbosum and F. clavus, isolated in the Volgograd (-V) and Rostov (-R) regions in different years, were observed. The isolate F. brachygibbosum-V showed high aggressiveness both at the sprout and seedling stages, while the isolate F. brachygibbosum-R was characterized by moderate aggressiveness only at the sprout stage. High pathogenicity of the species isolated from melons was established for other cucurbit crops. F. cf. inflexum was also pathogenic for watermelon and pumpkin, and F. brachygibbosum was pathogenic for pumpkin. The obtained data will have practical value for the development of biological control measures against Fusarium fungi and will be used in a melon breeding program for resistance to Fusarium wilt.

Infections with strains of the Cryptococcus neoformans species complex are responsible for over 100,000 deaths per year, predominantly due to meningitis in immunocompromised individuals. Despite much research, there are no licensed fungal vaccines available. Most experimental cryptococcal vaccine formulations have been tested in preclinical models using laboratory strains of C. neoformans, particularly H99 and KN99. However, to be effective, vaccines need to protect against the wide variety of cryptococcal isolates found worldwide, particularly in regions that have the highest burden of infections. Therefore, we explored vaccine-mediated protection of BALB/c mice against experimental cryptococcosis due to six C. neoformans strains originally isolated from patients with cryptococcal meningitis in Vietnam, Uganda, and Botswana. Two vaccines were tested: a live-attenuated C. neoformans vaccine lacking three chitin deacetylase genes, and a quadrivalent subunit protein vaccine adjuvanted with Cationic Adjuvant Formulation 01. When compared to unvaccinated mice, both vaccines provided significant protection against all six clinical strains. However, the degree of protection varied as a function of vaccine formulation and clinical strain. Lung leukocytes from vaccinated and infected mice had significantly increased antigen-stimulated interferon-gamma production compared with infected but unvaccinated mice. Thus, although the degree of protection varied, two cryptococcal vaccines significantly protected mice against experimental infection with cryptococcal strains representative of regions of the world that account for the majority of cryptococcal meningitis cases found globally. These data provide preclinical support for trialing vaccines in persons at high risk for developing cryptococcosis.